ARTICLE | Clinical News
Biosyn reports Phase I/II data
May 17, 2000 7:00 AM UTC
Biosyn (Philadelphia, Penn.) said its Oramed oral rinse to treat oral candidiasis in HIV/AIDS patients was safe and well tolerated. The placebo-controlled study also showed early signs of efficacy and...